Atlantis Medical Services Launches in Phuket to Advance Regenerative Medicine in Southeast Asia

Phuket, Thailand — Atlantis Bioscience, a biotechnology company headquartered in Singapore, has announced the establishment of Atlantis Medical Services in Phuket, Thailand. The new subsidiary expands the company’s capabilities into clinical and patient-facing aspects of regenerative medicine, supporting the growing regional demand for stem cell–based therapies and translational services.

Strengthening Translational and Clinical Capabilities

Atlantis Medical Services focuses on bridging laboratory research with clinical application by providing stem cell processing, characterisation, and therapy preparation. The centre’s current scope includes:

• Autologous Stem Cell Therapy

• Allogeneic Stem Cell Therapy

• Mesenchymal Stem Cell (MSC) Therapy

These services are designed to support clinicians, research partners, and wellness providers seeking reliable, science-based regenerative therapy pathways.

Accredited Laboratory Infrastructure

The Phuket facility operates under internationally recognised standards, supported by:

• ISO 9001:2015 accreditation, affirming its quality management system

• AAALAC accreditation, recognising compliance with established animal care and research guidelines

These accreditations provide a validated operational foundation for partners seeking consistent and traceable regenerative medicine workflows.

Investment in Patient Wellness and Delivery Infrastructure

As part of its expansion, Atlantis Medical Services is developing a structured patient-delivery ecosystem in Thailand. This includes securing purpose-designed villas to support patient wellness, monitoring, and post-treatment recovery.

This infrastructure is intended to offer clinical partners and investors a more complete end-to-end pathway for regenerative therapy programmes—from laboratory preparation to patient recovery environments.

Positioning Southeast Asia for Growth in Regenerative Medicine

The launch of Atlantis Medical Services in Phuket contributes to a broader regional plan to establish interconnected regenerative medicine hubs across Southeast Asia. The organisation aims to collaborate with hospitals, clinical specialists, research teams, and wellness operators to build an integrated ecosystem for cell-based therapies.

The launch of Atlantis Medical Services reflects a notable progression within Southeast Asia’s regenerative medicine environment. By integrating laboratory systems, therapy development, regulatory support, and patient recovery infrastructure, Atlantis Bioscience is contributing to a more coordinated regional framework for regenerative medicine research and application.